Otto Bock HealthCare LLP, a leading name in the orthopaedic and rehabilitation industry, is headquartered in the United States. Founded in 1919, the company has established itself as a pioneer in innovative healthcare solutions, particularly in prosthetics, orthotics, and mobility solutions. With a strong presence across North America and significant operations in Europe and Asia, Otto Bock is committed to enhancing the quality of life for individuals with mobility challenges. The company’s core offerings include advanced prosthetic limbs, custom orthotic devices, and cutting-edge mobility aids, all designed with a focus on user comfort and functionality. Otto Bock's dedication to research and development has positioned it as a market leader, recognised for its high-quality products and exceptional customer service. Notable achievements include numerous awards for innovation and a reputation for setting industry standards in patient care and rehabilitation technology.
How does Otto Bock HealthCare LLP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Otto Bock HealthCare LLP's score of 42 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Otto Bock HealthCare LLP, headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The organisation is a current subsidiary of Ottobock SE & Co. KGaA, which may influence its climate commitments and emissions reporting. As part of its climate strategy, Otto Bock HealthCare LLP inherits sustainability initiatives and targets from its parent company, Ottobock SE & Co. KGaA. However, there are no documented reduction targets or specific climate pledges available for Otto Bock HealthCare LLP at this time. The absence of emissions data and reduction initiatives suggests that the company may still be in the process of establishing its own climate commitments or may rely on the broader corporate family’s strategies for guidance.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 9,084,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 12,738,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 86,632,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Otto Bock HealthCare LLP's Scope 3 emissions, which decreased by 3% last year and increased by approximately 175% since 2020, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 78% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Otto Bock HealthCare LLP has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.